Clinical Trial Update: Radiotherapy Combined With GDP Chemotherapy in Stage I/II Extranodal Natural Killer/T-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating radiotherapy in combination with GDP chemotherapy for stage I/II Extranodal NK/T-cell lymphoma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extranodal Nk T-cell Lymphoma Nasal Type

Drugs mentioned

• CISPLATIN (cisplatin)
• DEXAMETHASONE (Dexamethasone)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Stage I/II Extranodal NK/T-cell Lymphoma | Phase 2 | Status: COMPLETED